Apellis Pharmaceuticals Inc. News
Cramer's Mad Money Recap 10/6: Dow, General Motors
Jim Cramer says it's hard to explain why stocks opened lower, but he thinks investors should have some conviction and look for buying opportunities.
5 Top Stock Gainers for Monday: Discovery, Apellis Pharma
Apellis Pharmaceuticals, Harley-Davidson, Dillard's, Children's Place and Harmony Gold are five top gainers for Monday.
Editas Medicine Falls as Goldman Sachs Initiates the Stock at Sell
Editas is initiated with a sell rating and $20 price target at Goldman Sachs.
Resilient Bull: Cramer's 'Mad Money' Recap (Wednesday 1/8/20)
Jim Cramer says this market environment is a strange merger of resilience, complacency and hubris. He explains how this feeds a stock rally.
Apellis Pharma Climbs on Upgrade to Overweight at JP Morgan
JP Morgan analysts see promising opportunities in Apellis's later-stage drug to treat the blood disorder PNH.
The Arena Group Q2 Gross Profit Nearly Doubles; Revenue Up 87%
The Arena Group, publisher of Sports Illustrated, TheStreet, Parade and more, reported that Q2 gross profit, revenue and digital-ad revenue jumped.
Will JetBlue Take Away the One Thing People Like About Spirit?
The takeover of the budget airline raises a key question for consumers.
Micron and Nvidia: Buy or Sell After Bearish Updates?
Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.